62019CO0832_INF
Order of the Vice-President of the Court of 26 February 2020 — Medac Gesellschaft für klinische Spezialpräparate v Commission
(Case C‑832/19 P(R))
(Appeal — Order for interim measures — Medicinal products for human use — Application for marketing authorisation for an orphan medicinal product —Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products — Urgency — Serious and irreparable damage — None)
Appeal — Grounds — Incorrect assessment of the facts and evidence — Inadmissibility — Review by the Court of the General Court’s findings with regard to national law — Possible only where the clear sense of the evidence has been distorted
(Art. 256(1), second para., TFEU; Statue of the Court of Justice, Art. 58, first para.)
(see para. 40, 41)
Operative part
1.
The appeal is dismisssed.
2.
Medac Gesellschaft für klinische Spezialpräparate mbH is ordered to pay the costs.